Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma

BACKGROUND: Spenic hemangiosarcoma (HSA) in dogs treated with surgery alone is associated with short survival times, and the addition of doxorubicin (DOX) chemotherapy only modestly improves outcome. The purpose of this study was to evaluate the impact of toceranib administration on progression free...

Descripción completa

Detalles Bibliográficos
Autores principales: Gardner, Heather L., London, Cheryl A., Portela, Roberta A., Nguyen, Sandra, Rosenberg, Mona P., Klein, Mary K., Clifford, Craig, Thamm, Douglas H., Vail, David M., Bergman, Phil, Crawford-Jakubiak, Martin, Henry, Carolyn, Locke, Jennifer, Garrett, Laura D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464614/
https://www.ncbi.nlm.nih.gov/pubmed/26062540
http://dx.doi.org/10.1186/s12917-015-0446-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464614/
https://www.ncbi.nlm.nih.gov/pubmed/26062540
http://dx.doi.org/10.1186/s12917-015-0446-1

Ejemplares similares